Center for Biospecimen Research & Development (CBRD) The Center for Biospecimen Research and Development (CBRD) was launched in 2015 and has replaced the BioRepository Center (BRC) shared resource presented at the last CCSG review on 2012. Under the direction of Andre Moreira, MD, PhD, Director of Surgical Pathology at NYU Langone Health (NYULH) and a recognized expert in lung pathology and biospecimen research, CBRD was created to support the increased demand across the NYULH research enterprise for standardized human biospecimens. CBRD focuses on improving the accessibility of human biospecimen resources to investigators and increasing institution-wide banking efforts and capacity. CBRD has implemented a campus-wide universal consent and policy for human biospecimen collection and storage to ensure regulatory compliance. CBRD provides well- annotated, high quality biospecimens that foster impactful translational research, thus guaranteeing the clinical relevance of basic findings. CBRD also supports the rapidly expanding portfolio of Perlmutter Cancer Center (PCC) investigator initiated clinical trials by facilitating acquisition, processing and distribution of biospecimens from enrolled patients. All of the samples collected are linked to clinical information obtained in our electronic medical record, EPIC.
The Specific Aims of CBRD are:
Aim 1) To maintain and expand a prospective Biospecimen Repository of PCC patient samples, as well as maintain and expand its linked clinicopathological information;
Aim 2) To process biospecimens, including by carrying out nucleic acid extraction and provide specialized Pathology support;
Aim 3) To stimulate collaborations involving the distribution of human biospecimens;
and Aim 4) To apply high quality control that meets national and international standards, as well as governance over biospecimen utilization.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
New York
United States
Zip Code
Xu, Yang; Taylor, Paul; Andrade, Joshua et al. (2018) Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma. Cancer Res 78:6539-6548
Gagner, Jean-Pierre; Zagzag, David (2018) Probing Glioblastoma Tissue Heterogeneity with Laser Capture Microdissection. Methods Mol Biol 1741:209-220
Tsay, Jun-Chieh J; Wu, Benjamin G; Badri, Michelle H et al. (2018) Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med 198:1188-1198
Martin, Patricia K; Marchiando, Amanda; Xu, Ruliang et al. (2018) Autophagy proteins suppress protective type I interferon signalling in response to the murine gut microbiota. Nat Microbiol 3:1131-1141
de la Parra, Columba; Ernlund, Amanda; Alard, Amandine et al. (2018) A widespread alternate form of cap-dependent mRNA translation initiation. Nat Commun 9:3068
Coux, Rémi-Xavier; Teixeira, Felipe Karam; Lehmann, Ruth (2018) L(3)mbt and the LINT complex safeguard cellular identity in the Drosophila ovary. Development 145:
Patibandla, Jay R; Fehniger, Julia E; Levine, Douglas A et al. (2018) Small cell cancers of the female genital tract: Molecular and clinical aspects. Gynecol Oncol 149:420-427
Fanok, Melania H; Sun, Amy; Fogli, Laura K et al. (2018) Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma. J Invest Dermatol 138:1116-1125
Berger, Ashton C; Korkut, Anil; Kanchi, Rupa S et al. (2018) A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. Cancer Cell 33:690-705.e9
Harper, Lamia; Balasubramanian, Divya; Ohneck, Elizabeth A et al. (2018) Staphylococcus aureus Responds to the Central Metabolite Pyruvate To Regulate Virulence. MBio 9:

Showing the most recent 10 out of 1170 publications